Seaport Therapeutics Inc. Common Stock
SPTX | NASDAQ
$19.60
-$1.50 (-7.11%)
At close: Oct 30, 2026, 4:00 PM ET
$19.60
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Net Income | -74.88M |
Depreciation & Amortization | 1.41M |
Stock-Based Compensation | 6.88M |
Other Working Capital | -5.2M |
Other Non-Cash Items | -3.42M |
Deferred Income Tax | n/a |
Change in Working Capital | -7.93M |
Operating Cash Flow | -77.94M |
Capital Expenditures | -356K |
Cash Acquisitions | n/a |
Purchase of Investments | -396.39M |
Sales Maturities Of Investments | 212.5M |
Other Investing Acitivies | n/a |
Investing Cash Flow | -184.25M |
Debt Repayment | n/a |
Common Stock Repurchased | n/a |
Dividend Paid | n/a |
Other Financial Acitivies | -874K |
Financial Cash Flow | -873K |
Net Cash Flow | -263.06M |
Free Cash Flow | -78.3M |
Adj. Free Cash Flow | -85.18M |
Maintenance CapEx | -356K |
Growth CapEx | n/a |
Owner Earnings | -78.3M |
Add to Watchlist
Select watchlists to add or remove SPTX